February 12, 2019

PLEASANTON, Calif., February 12, 2019 — To make the most advanced contact lens technologies available to patients at a more affordable price point, CooperVision, Inc. has unveiled the details of its updated patient rebate program, currently effective through June 30, 2019.


The following CooperVision patient rebates are now available:

  • MyDay® daily disposable - $130 off of (4) 180-packs or (8) 90-packs
  • clariti® 1 day - $200 off of (8) 90-packs or (24) 30-packs (new to CooperVision only) and $130 off of (8) 90-packs or (24) 30-packs (current CooperVision wearers)
  • Biofinity Energys® - $60 off (4) 6-packs
  • Biofinity® sphere - $30 off (4) 6-packs
  • Biofinity® toric, and Biofinity® multifocal - $50 off (4) 6-packs


“Through our close partnerships with eye care professionals, we understand that today’s practices are focused on upgrading patients to silicone hydrogel lenses—with an emphasis on 1-day—whenever possible,” said Simon Seshadri, Vice President, Marketing, North America, CooperVision. “We recognize the valuable role patient rebates can play in successfully transitioning patients to high oxygen contact lenses in various modalities. These rebates, combined with CooperVision’s unmatched portfolio, enable practitioners to fit a broader range of patients in contact lenses, ultimately helping to build their practices.”


Additional patient rebate terms and conditions apply. For additional information on CooperVision’s rebate program, please contact your CooperVision sales representative, or call 800 341-2020.


# # #


About CooperVision

CooperVision, a unit of The Cooper Companies, Inc. (NYSE:COO), is one of the world’s leading manufacturers of soft contact lenses. The Company produces a full array of monthly, two-week and daily disposable contact lenses, all featuring advanced materials and optics. CooperVision has a strong heritage of solving the toughest vision challenges such as astigmatism and presbyopia; and offers the most complete collection of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.


About the Cooper Companies

The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper  operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of families with its diversified portfolio of products and services focusing on women’s health, fertility and diagnostics. Headquartered in


Pleasanton, CA, Cooper has more than 10,000 employees with products sold in over 100 countries. For more information, please visit www.coopercos.com.